Bruker Corporation (BRKR)

Return on equity (ROE)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net income (ttm)	US$ in thousands	427,200	319,100	319,100	311,500	296,600	274,900	273,900	282,000	277,100	270,300	237,500	204,000	157,800	157,500	164,500	176,900	197,200	206,700	188,800	183,500
Total stockholders’ equity	US$ in thousands	1,377,200	1,208,800	1,231,200	1,180,300	1,113,800	937,000	970,500	1,017,000	1,070,500	1,075,600	1,002,000	967,700	961,200	952,100	897,400	915,600	906,800	845,200	860,800	913,200
ROE		31.02%	26.40%	25.92%	26.39%	26.63%	29.34%	28.22%	27.73%	25.89%	25.13%	23.70%	21.08%	16.42%	16.54%	18.33%	19.32%	21.75%	24.46%	21.93%	20.09%

December 31, 2023 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $427,200K ÷ $1,377,200K
= 31.02%

Bruker Corp's return on equity (ROE) has exhibited consistency and stability over the past quarters, ranging from 25.92% to 31.02%. The ROE performance has been notably strong, surpassing a 25% threshold consistently. This indicates that the company has been effectively generating profits from shareholder equity.

The slight fluctuation in ROE levels from quarter to quarter may be normal and not necessarily concerning, as long as the trend remains relatively stable. Bruker Corp's ability to consistently deliver ROE above 25% reflects positively on its operational efficiency and profitability, suggesting effective management of assets and equity to generate returns for shareholders.

Overall, the consistent performance of Bruker Corp's ROE demonstrates financial strength and effective utilization of resources to generate profits for shareholders.